WHO publishes first interim list of medical device authorities; AstraZeneca explores AI to reduce late-stage risk

The World Health Organization has issued its first interim list of medical device authorities, marking a step toward greater transparency in device regulation. The list is intended to guide manufacturers and regulators in identifying recognized authorities worldwide.

AstraZeneca disclosed that it is applying artificial-intelligence tools to assess and mitigate risks in late-stage clinical development. The company aims to use AI to improve decision-making and reduce uncertainty before final approval.

These developments highlight ongoing efforts to enhance regulatory oversight and incorporate advanced technologies in drug and device development.